diseas
caus
microbi
infect
present
throughout
human
evolut
larg
proport
result
viru
infect
sinc
new
human
virus
identifi
caus
wide
vari
diseas
virus
fall
welldocu
field
emerg
infecti
diseas
fact
three
distinct
situat
includ
categori
resurg
recurr
old
diseas
usual
caus
new
mutat
previous
known
agent
b
wellknown
human
diseas
epidemiolog
evid
transmiss
discoveri
newli
identifi
agent
c
diseas
truli
new
human
caus
preexist
zoonot
agent
commonli
cite
exampl
resurg
recurr
diseas
yearli
appear
new
antigen
differ
influenza
virus
new
variant
abl
evok
di
eas
host
caus
centuriesold
symptom
influenza
variat
occur
influenza
virus
two
kind
first
call
antigen
drift
occur
result
accumul
point
mutat
viru
surfac
protein
haemagglutinin
h
neuraminidas
n
lead
viral
escap
immun
respons
emerg
new
influenza
epidem
second
kind
chang
call
antigen
shift
occur
complet
genom
segment
encod
h
n
gene
one
viru
variant
replac
correspond
segment
anoth
variant
process
known
reassort
wildfowl
swine
endem
infect
influenza
viru
period
avian
human
influenza
virus
coinfect
pig
therefor
thought
pig
act
mix
pot
format
pandem
influenza
variant
allow
reassort
avian
swine
human
influenza
virus
occur
howev
spanish
pandem
strain
influenza
like
deriv
sole
strain
infect
human
swine
avian
subgroup
taubenberg
et
al
suggest
close
observ
new
pig
influenza
virus
could
highlight
presenc
potenti
new
human
pandem
variant
new
infecti
diseas
fall
latter
two
categori
new
diseas
new
agentcontinu
identifi
tabl
list
major
human
viral
diseas
identifi
sinc
tabl
also
includ
new
human
virus
link
specif
human
diseas
conclus
establish
exampl
hepat
g
viru
simon
et
al
b
linnen
et
al
borna
diseas
viru
lipkin
et
al
vandewoud
et
al
human
herpesviru
frenkel
et
al
also
includ
subgenom
viral
sequenc
identifi
human
tissu
name
human
retroviru
griffith
et
al
multipl
sclerosisassoci
retroviru
msrv
perron
et
al
yet
yield
complet
viru
genom
contributor
book
describ
mani
viral
diseas
truli
new
human
mostprob
caus
zoonosi
human
immunodefici
viru
type
homolog
old
world
monkey
viru
simian
immunodefici
viru
slv
suggest
recent
zoonosi
result
appear
new
human
diseas
acquir
immun
defici
syndrom
aid
allan
et
al
myer
et
al
anoth
exampl
new
zoonot
infect
hantaviru
pulmonari
lisieux
et
al
chang
et
al
linnen
et
al
simon
et
al
b
perron
et
al
griffith
et
al
nad
associ
human
diseas
syndrom
hp
demonstr
modern
molecular
virolog
instrument
identifi
new
human
pathogen
may
outbreak
respiratori
ill
mortal
rate
excess
report
border
region
new
mexico
arizona
utah
colorado
southwestern
usa
serolog
survey
initi
fail
identifi
known
agent
associ
respiratori
diseas
detect
crossreact
antibodi
previous
character
hantaviru
thought
unusu
hantavirus
previous
associ
human
diseas
north
america
associ
sever
predominantli
respiratori
ill
use
degener
pcr
primer
conserv
region
hantaviru
genom
led
identif
new
hantaviru
differ
known
hantavirus
nucleotid
level
nichol
et
al
usual
host
hantavirus
rodent
trap
rodent
four
corner
area
reveal
deer
mice
seroposit
new
hantaviru
outbreak
hp
subsequ
shown
associ
increas
deer
mous
popul
four
corner
area
four
month
hp
outbreak
cultur
system
establish
hantaviru
respons
hp
final
design
sin
nombr
viru
snv
elliott
et
al
exampl
newli
identifi
viru
caus
diseas
human
current
known
anim
insect
host
provid
hepat
c
viru
hcv
epidemiolog
evid
suggest
caus
nona
nonb
hepat
nanbh
infecti
origin
howev
convent
virolog
techniqu
fail
identifi
agent
even
though
evid
suggest
nanbh
caus
bloodborn
small
envelop
viru
readili
transmiss
chimpanze
hepat
c
viru
discov
screen
cdna
express
librari
prepar
viru
particl
pellet
chimpanze
high
nanbh
viru
titr
librari
screen
serum
patient
chronic
nanbh
one
clone
identifi
librari
one
million
clone
identif
clone
led
rapid
character
entir
viru
genom
hcv
formal
assign
new
viru
subfamili
within
famili
flavivirida
serolog
assay
demonstr
hcv
major
caus
nanbh
throughout
world
linnen
et
al
exampl
show
clearli
modern
molecular
biolog
techniqu
use
identifi
complet
new
virus
virus
associ
new
diseas
associ
wellcharacter
diseas
present
human
mani
year
identifi
emerg
viru
one
often
present
epidemiolog
data
clinic
specimen
reactiv
diagnost
reagent
avail
known
pathogen
primari
aim
therefor
identifi
new
infecti
agent
build
bodi
data
support
exist
causal
link
organ
diseas
viru
isol
cultur
vitro
long
definit
method
new
viru
character
often
first
method
employ
howev
mani
viral
diseas
approach
may
sever
limit
main
limit
need
permiss
host
cell
propag
new
viru
equal
import
effect
detect
method
show
infect
permiss
cell
classic
achiev
observ
cytopath
effect
detect
specif
viral
gene
product
isol
cell
cultur
work
viru
grow
vitro
detect
cytopath
effect
viral
gene
product
produc
inde
case
hp
discoveri
new
hantaviru
preced
establish
tissu
cultur
system
viru
propag
elliott
et
al
hcv
good
cultur
system
still
exist
year
discoveri
viru
keratinocyt
permiss
human
papillomaviru
type
replic
still
suitabl
routin
viru
isol
year
discoveri
molecular
hybrid
durst
et
al
electron
microscopi
em
diseas
tissu
vitro
infect
cell
cultur
anoth
method
employ
may
reveal
viru
particl
common
morpholog
featur
particular
viru
famili
lead
clue
character
viru
howev
em
suffer
artifactu
structur
present
prepar
materi
late
throughout
number
group
report
detect
em
viruslik
particl
human
tumour
dmochowski
et
al
feller
chopra
seman
et
al
denner
dorfman
contrast
dalton
demonstr
mani
viruslik
particl
may
simpli
result
breakdown
product
normal
cell
also
assumpt
viru
architectur
constant
famili
virus
alway
true
virus
classifi
em
requir
reclassif
follow
molecular
analysi
genom
structur
one
exampl
arteriviru
genu
coronaviruslik
cvl
superfamili
equin
anaemia
viru
eav
prototyp
genu
lactat
dehydrogenaseelev
viru
ldv
simian
haemorrhag
fever
viru
shfv
porcin
reproduct
respiratori
syndrom
viru
prrsv
morpholog
similar
virus
togavirida
togeth
genom
size
result
initi
classif
togaviru
famili
howev
arteriviru
genom
organ
replic
strategi
along
homolog
protein
rna
replicas
sinc
result
reclassif
arterivirus
within
cvl
superfamili
final
taxonom
fate
superfamili
still
decid
electron
microscopi
success
complet
new
structur
observ
observ
wormlik
virion
marburg
viru
viru
later
classifi
type
speci
filoviru
famili
kiley
et
al
standard
techniqu
base
immunofluoresc
assay
use
patient
sera
detect
viral
antigen
infect
patholog
specimen
use
success
detect
snv
hantaviru
pulmonari
syndrom
howev
patient
sera
clinic
specimen
react
known
viru
group
virusspecif
antibodi
method
provid
littl
use
inform
tendenc
use
increas
specif
routin
diagnost
test
work
identif
relat
yet
distinct
viru
strain
combin
immunolog
molecular
biolog
techniqu
use
success
identifi
new
human
virus
gener
scheme
immunoscreen
outlin
figur
reli
product
highqual
cdna
express
librari
deriv
infect
tissu
case
positivesens
rna
virus
directli
viru
present
plasma
three
hepat
virus
identifi
use
techniqu
hepat
c
viru
identifi
choo
et
al
follow
isol
virusspecif
cdna
clone
nanbinfect
chimpanze
plasma
describ
earlier
approach
success
identifi
hepat
g
viru
linnen
et
al
viru
found
almost
ident
viru
gbvc
anoth
human
hepatitisassoci
viru
simon
et
al
identifi
use
degen
erat
pcr
primer
addit
hepat
e
viru
hev
specif
cdna
clone
identifi
cdna
librari
deriv
total
rna
isol
bile
juic
two
experiment
infect
rhesu
monkey
uchida
et
al
absolut
requir
cdna
immunoscreen
avail
high
antibodi
titr
immun
serum
patient
experiment
infect
anim
howev
sera
may
also
contain
mani
antibodi
crossreact
human
antigen
express
librari
lead
falseposit
clone
identifi
particular
problem
diseas
autoantibodi
common
requir
larg
repres
cdna
librari
made
absenc
knowledg
viru
genom
entail
use
randomli
prime
cdna
rather
convent
oligodt
prime
librari
particularli
relev
case
hcv
viral
positivesens
rna
genom
contain
polyuridin
rather
polyadenin
tail
kolykhalov
et
al
use
power
molecularbas
method
analys
wellcharacter
biolog
specimen
creat
new
era
molecular
identif
emerg
virus
major
advantag
molecular
methodolog
abil
look
rapidli
new
virus
known
virus
relat
previous
undetect
member
establish
viru
famili
resoundingli
success
discoveri
genit
papillomavirus
durst
et
al
widespread
use
polymeras
chain
reaction
pcr
avail
extens
sequenc
databas
viru
genom
often
possibl
design
pcr
primer
conserv
region
viru
genom
possibl
survey
sampl
primer
look
presenc
given
viru
new
patholog
specimen
power
identif
tool
must
appli
care
common
problem
encount
natur
assay
condit
addit
gener
problem
pcr
contamin
small
modif
dramat
alter
sensit
pcr
signal
produc
without
appropri
control
condit
accident
contriv
amplifi
detect
mani
irrelev
dna
sequenc
diseas
addit
detect
viru
genom
diseas
tissu
automat
produc
link
viru
diseas
frederick
relman
particularli
relev
pcr
screen
known
new
virus
exampl
number
known
infecti
agent
implic
pathogenesi
multipl
sclerosi
ms
allen
brankin
kurtzk
challon
et
al
perron
et
al
none
associ
conclus
prove
caus
ms
rice
look
new
member
viru
famili
degener
pcr
primer
design
conserv
region
viru
genom
nucleic
acid
level
prefer
design
conserv
amino
acid
region
viru
protein
base
codon
degeneraci
amino
acid
latter
cover
much
wider
varieti
nucleic
acid
sequenc
therefor
diverg
use
look
new
viru
genom
mani
group
publish
degener
pcr
primer
divers
viru
famili
tabl
use
success
identifi
mani
new
virus
rang
human
virus
gbvc
hepat
g
viru
simon
et
al
snv
nichol
et
al
griffith
et
al
mani
anim
virus
pig
endogen
retroviru
perv
patienc
et
al
walley
dermal
sarcoma
viru
zhang
martineau
macaqu
gammaherpesviru
retroperiton
fibromatosi
herpesviru
rfhv
mn
howev
lack
specif
control
degener
primer
mean
standard
achiev
exist
member
viru
famili
therebi
guarante
detect
unknown
viru
problem
inappropri
amplif
condit
lead
product
mani
fals
posit
case
amplif
therefor
necessari
optim
care
degener
pcr
condit
relev
control
usual
requir
optim
reaction
buffer
primer
anneal
temperatur
often
use
nest
seminest
pcr
strategi
addit
special
amplif
techniqu
touchdown
pcr
often
improv
pcr
amplif
use
degener
primer
et
al
zhang
martineau
recent
array
molecular
techniqu
adapt
use
new
viru
discoveri
pure
nucleic
acidbas
make
assumpt
natur
viral
agent
present
method
evolv
one
aim
molecular
medicin
identifi
differ
nucleic
acid
level
diseaseassoci
tissu
normal
tissu
methodolog
common
one
nucleic
acid
popul
uninfect
driver
hybrid
excess
second
popul
infect
test
remov
common
sequenc
therebi
enrich
target
sequenc
uniqu
tester
method
broadli
divid
physic
subtract
techniqu
pcrbase
kinet
enrich
techniqu
rel
merit
ultim
depend
natur
nucleic
acid
sampl
analys
physic
subtract
techniqu
applic
detect
differ
mrna
express
one
cell
type
anoth
earli
use
techniqu
simpli
involv
solut
hybrid
excess
driver
mrna
cdna
made
tester
mrna
common
sequenc
present
sampl
form
cdna
mrna
hybrid
leav
uniqu
sequenc
tester
cdna
unhybrid
doublestrand
hybrid
remov
hydroxyapatit
chromatographi
exploit
higher
affin
hydroxyapatit
doublestrand
nucleic
acid
remain
subtract
cdna
use
construct
subtract
cdna
librari
label
enrich
cdna
probe
librari
screen
method
use
combin
immunoscreen
identifi
viru
associ
borna
diseas
lipkin
et
al
vandewoud
et
al
borna
diseas
infecti
neurolog
diseas
occur
sporad
hors
sheep
central
europ
may
also
associ
certain
human
neuropsychiatr
disord
bode
et
al
modern
version
techniqu
develop
use
cdna
librari
construct
clone
vector
stratagen
la
jolla
usa
librari
made
driver
tester
cell
line
tissu
sampl
figur
method
use
isol
rare
cdna
less
abund
colon
hepat
carcinoma
tissu
schweinfest
et
al
kzap
vector
allow
rescu
directli
librari
singlestrand
dna
phagemid
dna
ssdna
doublestrand
dna
plasmid
dsdna
contain
repres
cdna
initi
method
made
use
nondirect
clone
cdna
librari
schweinfest
et
al
howev
newer
vector
allow
product
direct
clone
cdna
use
modifi
version
techniqu
figur
primari
cdna
librari
amplifi
approxim
million
plaqueform
unit
tester
librari
use
produc
singlestrand
phage
dna
amount
driver
librari
use
produc
doublestrand
plasmid
dna
vitro
transcrib
rna
incorpor
dutpbiotin
made
driver
dsdna
use
promot
locat
vector
biotinyl
rna
complementari
tester
ssdna
subsequ
hybrid
tester
ssdna
complementari
hybrid
remov
use
streptavidin
bead
multipl
round
hybrid
subtract
perform
enrich
rare
cdna
tester
popul
follow
subtract
tester
ssdna
made
doublestrand
transform
escherichia
coli
repres
enrich
subtract
librari
analys
represent
differ
analysi
represent
differ
analysi
rda
repres
first
global
approach
analysi
differ
cellular
genom
although
origin
develop
look
differ
tumour
cell
genom
dna
normal
cell
lisitsyn
et
al
lisitsyn
wigler
adapt
identifi
differ
mrna
express
hubank
schatz
techniqu
use
success
identifi
new
human
virus
associ
kaposi
sarcoma
name
human
herpesviru
chang
et
al
virus
gbva
b
simon
et
al
relat
gbvchgv
simon
et
al
linnen
et
al
associ
viral
hepat
controversi
rda
use
identifi
human
herpesviru
sequenc
plaqu
patient
multipl
sclerosi
challon
et
al
cdna
clone
infecti
creutzfeldtjakob
brain
fraction
homolog
known
databas
sequenc
dron
manuelidi
represent
differ
analysi
combin
three
element
represent
subtract
enrich
kinet
enrich
procedur
carri
two
stage
first
compris
prepar
represent
driver
tester
dna
cdna
small
restrict
fragment
deriv
start
nucleic
acid
ligat
oligonucleotid
adaptor
amplifi
pcr
second
stage
compris
reiter
hybridizationselect
step
figur
prior
hybrid
oligonucleotid
adaptor
use
initi
represent
pcr
step
cleav
driver
tester
amplicon
new
set
defin
differ
sequenc
adaptor
ligat
onto
end
tester
amplicon
hybrid
tester
driver
amplicon
mixtur
molecul
treat
dna
polymeras
add
copi
defin
oligonucleotid
end
selfann
tester
dna
fragment
defin
oligonucleotid
adaptorprim
use
pcr
mixtur
testerann
dna
fragment
particip
exponenti
amplif
yield
differ
product
cycl
cleavag
old
adaptor
ligat
new
adaptor
differ
product
hybrid
excess
driver
pcr
amplif
repeat
two
three
time
final
pcr
product
clone
analys
suppress
subtract
hybrid
ssh
base
similar
principl
rda
describ
june
diatchenko
et
al
techniqu
design
select
amplifi
differenti
express
cdna
fragment
simultan
suppress
nontarget
dna
amplif
like
rda
use
varieti
nucleic
acid
target
figur
method
represent
tester
driver
dna
prepar
restrict
enzym
digest
tester
dna
subdivid
two
portion
ligat
differ
oligonucleotid
adaptor
end
howev
contrast
rda
ssh
involv
two
hybrid
step
first
excess
denatur
driver
cdna
ad
popul
denatur
tester
cdna
owe
secondord
reaction
kinet
hybrid
singlestrand
molecul
correspond
highand
lowabund
sequenc
becom
normal
normal
occur
anneal
process
faster
abund
molecul
result
proport
lowabund
tester
cdna
remain
singlestrand
second
hybrid
two
primari
hybrid
sampl
mix
togeth
sinc
sampl
heatdenatur
remain
normal
subtract
singlestrand
tester
cdna
abl
associ
form
new
hybrid
hybrid
differ
oligonucleotid
adaptor
sequenc
end
fresh
denatur
driver
dna
ad
enrich
differenti
express
sequenc
follow
hybrid
dna
polymeras
end
fill
entir
popul
pcr
amplifi
oligonucleotid
adaptor
hybrid
adaptor
either
end
suppress
pcr
amplif
owe
format
panhandl
structur
termin
repeat
primer
site
diatchenko
et
al
hybrid
differ
adaptor
either
end
exponenti
amplifi
final
nest
pcr
intern
common
primer
allow
clone
differ
product
analysi
method
yet
use
viru
identif
like
rda
enorm
potenti
differenti
display
revers
transcript
pcr
ddrtpcr
describ
liang
parde
applic
differ
mrna
express
cell
essenti
semirandomli
prime
pcr
method
base
assumpt
everi
individu
mrna
molecul
revers
transcrib
amplifi
pcr
use
origin
principl
describ
ddrtpcr
develop
refin
ayala
et
al
figur
four
composit
primer
contain
base
common
sequenc
end
follow
polyt
end
mix
base
c
g
plu
fix
base
design
one
improv
primer
set
illustr
figur
ayala
et
al
primer
use
prime
first
strand
cdna
synthesi
driver
tester
mrna
total
rna
addit
composit
arbitrari
primer
contain
sequenc
cgtgaattcg
ad
end
differ
random
sequenc
also
design
use
primer
radioact
label
pcr
reaction
involv
initi
lowstring
cycl
follow
highstring
cycl
pcr
product
resolv
either
nativ
denatur
polyacrylamid
gel
differenti
express
novel
mrna
repres
specif
band
tester
track
gel
compar
driver
greater
number
differ
arbitrari
primer
use
higher
chanc
observ
differ
howev
new
primer
produc
eight
pcr
reaction
four
tester
four
driver
number
becom
limit
differenti
display
band
excis
origin
gel
reamplifi
clone
studi
like
ssh
ddrtpcr
yet
result
identif
new
viru
right
combin
differ
method
need
use
varieti
sampl
like
aris
new
viru
discoveri
biolog
sampl
avail
cellfre
choic
method
limit
knowledg
natur
viral
genom
ie
dna
positivesens
rna
negativesens
rna
degener
pcr
rda
ssh
method
applic
infect
cell
line
tissu
sampl
method
applic
natur
new
viral
genom
known
global
method
analysi
would
studi
new
mrna
speci
use
physic
subtract
method
requir
rel
abund
suppli
polya
mrna
may
limit
techniqu
howev
sinc
method
avoid
pcr
thu
pcr
contamin
problem
pcrbase
method
still
use
anoth
disadvantag
physic
subtract
method
requir
cdna
librari
costli
timeconsum
make
rda
ssh
disadvantag
requir
complex
restrict
digest
primer
ligat
hybrid
pcr
contamin
common
laboratori
dna
initi
stage
lead
fals
posit
clone
addit
failur
one
stage
lead
differ
pcr
product
falseposit
imposs
control
work
authent
sampl
rda
method
timeconsum
compar
ssh
ssh
also
requir
less
initi
tester
driver
nucleic
acid
rda
howev
like
ddrtpcr
ssh
yet
prove
field
new
viru
discoveri
differenti
display
sensit
prone
fals
posit
although
subtract
method
wan
et
al
method
also
disadvantag
primer
depend
pcr
amplif
owe
use
polyt
primer
ddrtpcr
allow
detect
positivesens
viru
genom
altern
tail
polya
howev
possibl
design
use
altern
polynucleotid
primer
cover
divers
viru
group
overal
ddrtpcr
quick
provid
qualit
result
differ
two
sampl
follow
identif
candid
clone
analysi
character
whether
candid
truli
exogen
origin
requir
northern
southern
blot
analysi
andor
pcr
reveal
whether
clone
exogen
analysi
open
read
frame
show
whether
clone
encod
known
homolog
protein
whether
relat
known
virus
howev
mani
major
advanc
technolog
sequencedbas
approach
new
viru
identif
lead
mislead
conclus
particular
prove
link
diseas
uncultur
viru
identifi
nucleic
acid
sequenc
stimul
much
debat
led
format
revis
guidelin
defin
causal
relationship
viru
diseas
frederick
relman
presenc
viral
sequenc
within
diseas
tissu
absenc
corrobor
data
insuffici
prove
new
viru
caus
particular
diseas
detect
virus
may
reflect
either
presenc
viru
surround
cell
tissu
abil
viru
replic
within
microenviron
diseas
tissu
rather
viru
caus
observ
diseas
exampl
hantaviru
pulmonari
syndrom
layer
evid
compil
reach
conclus
diseas
causat
opposit
true
hgv
follow
viru
discoveri
accumul
data
indic
viru
caus
hepat
human
rather
viru
subgroup
individu
caus
appar
diseas
alter
et
al
b
list
diseas
possibl
microbi
aetiolog
still
larg
new
pathogen
like
identifi
molecular
biolog
method
describ
specif
diseas
kawasaki
syndrom
kawasaki
et
al
sarcoidosi
newman
et
al
multipl
sclerosi
allen
brankin
well
gener
diseas
group
neurodegen
disord
form
arthriti
inflammatori
bowel
diseas
autoimmun
diseas
certain
cancer
may
infecti
origin
may
make
new
aetiolog
agent
hard
defin
agent
part
multifactori
origin
diseas
diseas
may
result
multipl
viral
exposur
case
dengu
fever
altern
virus
may
act
trigger
diseas
caus
diseas
follow
longterm
chronic
asymptomat
infect
clearli
molecular
biolog
approach
help
unravel
caus
mani
preexist
diseas
also
enabl
rapid
identif
new
virul
emerg
infecti
diseas
